IVRTX
Price
$27.09
Change
+$0.41 (+1.54%)
Updated
Apr 17 closing price
Net Assets
149.39M
VRTPX
Price
$20.88
Change
+$0.31 (+1.51%)
Updated
Apr 17 closing price
Net Assets
9.54B
Ad is loading...

IVRTX vs VRTPX

Header iconIVRTX vs VRTPX Comparison
Open Charts IVRTX vs VRTPXBanner chart's image
VY® CBRE Real Estate S2
Price$27.09
Change+$0.41 (+1.54%)
VolumeN/A
Net Assets149.39M
Vanguard Real Estate II Index
Price$20.88
Change+$0.31 (+1.51%)
VolumeN/A
Net Assets9.54B
IVRTX vs VRTPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IVRTX vs. VRTPX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVRTX is a StrongBuy and VRTPX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VRTPX has more cash in the bank: 9.54B vs. IVRTX (149M). VRTPX pays higher dividends than IVRTX: VRTPX (3.92) vs IVRTX (2.37). IVRTX was incepted earlier than VRTPX: IVRTX (23 years) vs VRTPX (8 years). IVRTX (1.43) is less costly to investors than VRTPX (0.08). IVRTX is a more actively managed with annual turnover of: 73.00 vs. VRTPX (6.00). IVRTX has a lower initial minimum investment than VRTPX: IVRTX (0) vs VRTPX (100000000). VRTPX annual gain was more profitable for investors over the last year : 15.11 vs. IVRTX (7.55). VRTPX return over 5 years is better than : 37.45 vs. IVRTX (-1.78).
IVRTXVRTPXIVRTX / VRTPX
Total Expense Ratio1.150.081,437%
Annual Report Gross Expense Ratio1.430.081,788%
Fund Existence23 years8 years-
Gain YTD-5.924-1.569378%
Front LoadN/AN/A-
Min. Initial Investment0100000000-
Min. Initial Investment IRAN/AN/A-
Net Assets149M9.54B2%
Annual Yield % from dividends2.373.9260%
Returns for 1 year7.5515.1150%
Returns for 3 years-34.33-9.68355%
Returns for 5 years-1.7837.45-5%
Returns for 10 years-8.77N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTCH29.020.37
+1.29%
Match Group
VINC0.28N/A
N/A
Vincerx Pharma Inc
FPI9.99-0.04
-0.40%
Farmland Partners
LCTX0.41-0.01
-1.63%
Lineage Cell Therapeutics
DAVA17.10-0.30
-1.72%
Endava plc